Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

DSpace Repository

Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

Author: Pistrosch, Frank; Matschke, Jan B.; Schipp, Dorothea; Schipp, Bernhard; Henkel, Elena; Weigmann, Ingo; Sradnick, Jan; Bornstein, Stefan R.; Birkenfeld, Andreas L.; Hanefeld, Markolf
Tübinger Autor(en):
Birkenfeld, Andreas L.
Published in: Diabetologia (2021), Bd. 64, H. 12, S. 2701-2712
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00125-021-05562-9
ISSN: 1432-0428
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)